Literature DB >> 8006441

Epidemiologic investigation of nonmelanoma skin cancer mortality: the Rhode Island Follow-Back Study.

M A Weinstock1.   

Abstract

The Rhode Island Follow-Back Study was initiated to elucidate the magnitude and characteristics of nonmelanoma skin cancer mortality. All deaths reported among Rhode Island residents during 1979 through 1987 and attributed to nonmelanoma skin cancer were investigated and medical records sought. Most were misclassified, primarily due to squamous cell carcinoma of mucosal surfaces in the head and neck. In Rhode Island and nationally, this source of misclassification is increasingly frequent. Appropriate adjustment of national statistics for misclassification reveals a consistent decline in nonmelanoma skin cancer mortality rates from 1969 through 1988, although the actual numbers of deaths are increasing due to growth and aging of the population. Examination of the records of those Rhode Island residents who did die from nonmelanoma skin cancer demonstrated that most had squamous cell carcinoma, and many of those arose from the ear. These analyses suggest that particular emphasis should be placed on the ear in public health campaigns geared toward the prevention and early detection of nonmelanoma skin cancer.

Entities:  

Mesh:

Year:  1994        PMID: 8006441     DOI: 10.1111/1523-1747.ep12385735

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).

Authors:  Andrea Luísa Suárez; Peter Louis; Jasmine Kitts; Klaus Busam; Patricia L Myskowski; Richard J Wong; Chih-Shan Jason Chen; Philip Spencer; Mario Lacouture; Melissa P Pulitzer
Journal:  J Am Acad Dermatol       Date:  2015-10-02       Impact factor: 11.527

2.  Focus Issue on Squamous Cell Carcinoma: Practical Concerns Regarding the 7th Edition AJCC Staging Guidelines.

Authors:  D Buethe; C Warner; J Miedler; C J Cockerell
Journal:  J Skin Cancer       Date:  2010-11-22

3.  Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer.

Authors:  Camilla Fusi; Serena Materazzi; Daiana Minocci; Vincenza Maio; Teresa Oranges; Daniela Massi; Romina Nassini
Journal:  J Invest Dermatol       Date:  2014-03-18       Impact factor: 8.551

4.  Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study.

Authors:  Michelle R Iannacone; Wei Wang; Heather G Stockwell; Kathleen O'Rourke; Anna R Giuliano; Vernon K Sondak; Jane L Messina; Richard G Roetzheim; Basil S Cherpelis; Neil A Fenske; Dana E Rollison
Journal:  BMC Cancer       Date:  2012-09-20       Impact factor: 4.430

5.  Molecular markers in cutaneous squamous cell carcinoma.

Authors:  Anthony P Tufaro; Jim C-M Chuang; Nijaguna Prasad; Alice Chuang; Tony C Chuang; Anne C Fischer
Journal:  Int J Surg Oncol       Date:  2011-08-09

Review 6.  Emerging concepts and recent advances in basal cell carcinoma.

Authors:  Mariam Totonchy; David Leffell
Journal:  F1000Res       Date:  2017-12-04

Review 7.  Effect of estrogens on skin aging and the potential role of SERMs.

Authors:  Susan Stevenson; Julie Thornton
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

Review 8.  Metatypical basal cell carcinoma: a clinical review.

Authors:  Mauro Tarallo; Emanuele Cigna; Riccardo Frati; Sergio Delfino; Daniele Innocenzi; Umberto Fama; Annamaria Corbianco; Nicolò Scuderi
Journal:  J Exp Clin Cancer Res       Date:  2008-11-07

9.  Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study.

Authors:  Berta Suárez; Gonzalo López-Abente; Carmen Martínez; Carmen Navarro; Maria José Tormo; Stefano Rosso; Simon Schraub; Lorenzo Gafà; Hélène Sancho-Garnier; Janine Wechsler; Roberto Zanetti
Journal:  BMC Public Health       Date:  2007-07-26       Impact factor: 3.295

Review 10.  Estrogens and aging skin.

Authors:  M Julie Thornton
Journal:  Dermatoendocrinol       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.